Back to Search
Start Over
Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM)
- Authors :
- Richter, Joshua Ryan Martin, Thomas G. Vij, Ravi Cole, Craig and Atanackovic, Djordje Zonder, Jeffrey A. Kaufman, Jonathan L. and Mikhael, Joseph Bensinger, William Dimopoulos, Meletios A. and Zimmerman, Todd M. Lendvai, Nikoletta Hari, Parameswaran and Ocio, Enrique M. Gasparetto, Cristina Kumar, Shaji Oprea, Corina Charpentier, Eric Strickland, Stephen Anthony Miguel, Jesus San
- Publication Year :
- 2016
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......2127..272031d1d5ea34dc09ba93ecadedad26